Northwest Biotherapeutics NWBO
OTC NWBO
$0.15 -0.01 (-6.25%)
At close: Sep 28, 2026 · 4:00 PM EDT

Northwest Biotherapeutics (NWBO) Share-based Compensation (2010 - 2026)

Updated

Northwest Biotherapeutics (NWBO) recorded Share-based Compensation of $181,000 in Q2 2026, down 50.3% from $364,000 a year earlier and down 37.2% from the prior quarter.

Analysis

Northwest Biotherapeutics (NWBO) Share-based Compensation (2010 - 2026) Analysis & Trends

On a TTM basis, Northwest Biotherapeutics' Share-based Compensation came in at $927,000 as of Jun 30, 2026, down 50.9% year-over-year; for FY2025, it came in at $1.21 million, down 65.1% from FY2024.

  • Annual Share-based Compensation has declined for five straight years, with a five-year compound annual growth rate of -52.9% (FY2020 to FY2025).
  • Across earlier years, Share-based Compensation came in at $3.46 million in FY2024 (-21.6%), $4.41 million in FY2023 (-64.2%), $12.3 million in FY2022 (-20.6%) and $15.5 million in FY2021 (-70.3%).
  • The Q2 2026 figure is the lowest quarterly Share-based Compensation since Q2 2020.
  • On a year-over-year basis, Share-based Compensation has declined for eight consecutive quarters, with an average decline of 57.4% over the last eight quarters.
  • Peak year-over-year performance for Share-based Compensation in the last five years was growth of 314.7% in Q2 2024, against a decline of 96.8% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $288,000 (Q1 2026), $185,000 (Q4 2025) and $273,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Northwest Biotherapeutics 250.40 Mn 240.41 Mn - 181,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 181,000.00
Mar 31, 2026 288,000.00
Dec 31, 2025 185,000.00
Sep 30, 2025 273,000.00
Jun 30, 2025 364,000.00
Mar 31, 2025 385,000.00
Dec 31, 2024 454,000.00
Sep 30, 2024 685,000.00
Jun 30, 2024 1.15 Mn
Mar 31, 2024 1.16 Mn
Dec 31, 2023 1.58 Mn
Sep 30, 2023 1.62 Mn
Jun 30, 2023 278,000.00
Mar 31, 2023 933,000.00
Dec 31, 2022 2.56 Mn
Sep 30, 2022 3.36 Mn
Jun 30, 2022 5.76 Mn
Mar 31, 2022 617,000.00
Dec 31, 2021 866,000.00
Sep 30, 2021 1.26 Mn
API Access

Northwest Biotherapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=NWBO&period=max&api_key=YOUR_API_KEY